Coronary Heart Disease in Postmenopausal Recipients of Estrogen Plus Progestin Therapy: Does the Increased Risk Ever Disappear?

Authors:

Abstract
Some postmenopausal women who receive hormone replacement therapy have an increased risk for coronary heart disease (CHD). These data from the Women's Health Initiative trial examine how the timing... Background: Estrogen plus progestin therapy increases the risk for coronary heart disease (CHD) in postmenopausal women. However, this increased risk might be limited to the first years of use and ...

This publication has 28 references indexed in Scilit: